Sanara MedTech Inc

SMTI

Company Profile

  • Business description

    Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

  • Contact

    1200 Summit Avenue
    Suite 414
    Fort WorthTX76102
    USA

    T: +1 817 529-2300

    E: [email protected]

    https://www.sanaramedtech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    108

Stocks News & Analysis

stocks

Chart of the Week: BHP’s valuation hits historic levels

BHP and peers are trading as if the copper boom is here to stay.
stocks

3 cheap wide moat growth stocks

4 and 5 star companies that can protect and grow their earnings.
stocks

ASX biotech expands diagnostics portfolio after FDA approval

FDA nod adds another growth driver for ASX share.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,910.9036.400.41%
CAC 408,194.6854.090.66%
DAX 4025,745.03207.280.81%
Dow JONES (US)51,461.90631.21-1.21%
FTSE 10010,770.5782.100.77%
HKSE24,604.29109.49-0.44%
NASDAQ25,978.433.14-0.01%
Nikkei 22564,136.25213.250.33%
NZX 50 Index13,756.59133.870.98%
S&P 5007,551.810.000.00%
S&P/ASX 2008,732.4035.900.41%
SSE Composite Index3,875.6016.00-0.41%

Market Movers